Saturday, February 23, 2013
We are excited to be part of the program project NF-kB Regulated Metabolic Shifts in Childhood Sarcomas directed by Dr. Peter Houghton at Nationwide Children's Hospital and newly funded by NIH/NCI. The studies within the project led by Dr. Denis Guttridge in which we will participate will investigate the NFkB signaling pathway in rhabdomyosarcoma.
Monday, February 4, 2013
The recent change in policy by Dupont with regard to the Oncomouse patent opens the door to academic-pharma collaboration. It may also be possible to streamline development of novel drug testing by creating a non-profit company or organization for this specific purpose. Rhabdomyosarcoma, Inc? Would members of the community have interest in such an endeavor?